Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Acquires Rights To Market And Distribute Generic Seroquel Xr® In The U.S.

Woodcliff Lake, NJ, October 29, 2012 – Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa Pharmaceuticals, LLC to acquire …

Share